Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Action Against Illegally Promoted, Foreign-Manufactured, Unapproved Prescription Drugs

Action Against Illegally Promoted, Foreign-Manufactured, Unapproved Prescription Drugs United the the recommends the Action Promoted, States Against Illegally small, "personal-use" risks, agency of sold abroad but not Foreign-Manufactured, Unapproved quantities drugs following: The FDA has that the • Monitor and re¬ Prescription Prescription Drugs: Drugs: approved here, provided drugs patients frequently, observed an increase in the do unreasonable move restraints not often. promotion pose safety risks, and of that their use is not in the and devices importation unapproved pre¬ promoted Apply adjust properly of Un¬ United and that are for a maintain and to scription drugs foreign origin. States, they body alignment patient serious condition for which there is no comfort. present approved prescription drugs serious and effectiveness con¬ treatment available in this Allow the use of restraints safety satisfactory only by cerns. In view of the has This was to and a defined for this, agency country. policy designed prescription strictly issued alert discretion for of an the release small recently import provide period. mail-order • of medicines with which in¬ Define and communicate a clear in¬ unapproved drugs against quantities six dividuals the United States overseas to stitutional the use of promoted by companies. on returning policy restraints, of these ad¬ have been treated http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA American Medical Association

Action Against Illegally Promoted, Foreign-Manufactured, Unapproved Prescription Drugs

JAMA , Volume 267 (11) – Mar 18, 1992

Action Against Illegally Promoted, Foreign-Manufactured, Unapproved Prescription Drugs

Abstract

United the the recommends the Action Promoted, States Against Illegally small, "personal-use" risks, agency of sold abroad but not Foreign-Manufactured, Unapproved quantities drugs following: The FDA has that the • Monitor and re¬ Prescription Prescription Drugs: Drugs: approved here, provided drugs patients frequently, observed an increase in the do unreasonable move restraints not often. promotion pose safety risks, and of that their use is not in the and devices...
Loading next page...
 
/lp/american-medical-association/action-against-illegally-promoted-foreign-manufactured-unapproved-i8bKcm4k2F

References (0)

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Publisher
American Medical Association
Copyright
Copyright © 1992 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
0098-7484
eISSN
1538-3598
DOI
10.1001/jama.1992.03480110018006
Publisher site
See Article on Publisher Site

Abstract

United the the recommends the Action Promoted, States Against Illegally small, "personal-use" risks, agency of sold abroad but not Foreign-Manufactured, Unapproved quantities drugs following: The FDA has that the • Monitor and re¬ Prescription Prescription Drugs: Drugs: approved here, provided drugs patients frequently, observed an increase in the do unreasonable move restraints not often. promotion pose safety risks, and of that their use is not in the and devices importation unapproved pre¬ promoted Apply adjust properly of Un¬ United and that are for a maintain and to scription drugs foreign origin. States, they body alignment patient serious condition for which there is no comfort. present approved prescription drugs serious and effectiveness con¬ treatment available in this Allow the use of restraints safety satisfactory only by cerns. In view of the has This was to and a defined for this, agency country. policy designed prescription strictly issued alert discretion for of an the release small recently import provide period. mail-order • of medicines with which in¬ Define and communicate a clear in¬ unapproved drugs against quantities six dividuals the United States overseas to stitutional the use of promoted by companies. on returning policy restraints, of these ad¬ have been treated

Journal

JAMAAmerican Medical Association

Published: Mar 18, 1992

There are no references for this article.